Mary Lou Perry

13.7k total citations · 10 hit papers
26 papers, 2.6k citations indexed

About

Mary Lou Perry is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Nutrition and Dietetics. According to data from OpenAlex, Mary Lou Perry has authored 26 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Physiology and 5 papers in Nutrition and Dietetics. Recurrent topics in Mary Lou Perry's work include Diabetes Management and Research (7 papers), Diet and metabolism studies (5 papers) and Diabetes Treatment and Management (5 papers). Mary Lou Perry is often cited by papers focused on Diabetes Management and Research (7 papers), Diet and metabolism studies (5 papers) and Diabetes Treatment and Management (5 papers). Mary Lou Perry collaborates with scholars based in United States, Australia and Mexico. Mary Lou Perry's co-authors include B. Sears, Florence M. Brown, Billy S. Collins, Grazia Aleppo, Sarah K. Lyons, Marisa E. Hilliard, Nuha A. ElSayed, Vanita R. Aroda, Raveendhara R. Bannuru and Kamlesh Khunti and has published in prestigious journals such as Diabetes Care, Nutrients and Lipids in Health and Disease.

In The Last Decade

Mary Lou Perry

26 papers receiving 2.5k citations

Hit Papers

9. Pharmacologic Approach... 2015 2026 2018 2022 2022 2022 2015 2022 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Lou Perry United States 14 1.7k 577 452 451 391 26 2.6k
Nuha A. ElSayed United States 15 1.9k 1.1× 598 1.0× 369 0.8× 372 0.8× 460 1.2× 24 2.6k
Dennis Bruemmer United States 15 1.8k 1.1× 639 1.1× 305 0.7× 411 0.9× 387 1.0× 21 2.8k
Diana Isaacs United States 20 2.3k 1.4× 690 1.2× 352 0.8× 520 1.2× 419 1.1× 63 3.1k
Rakesh Sahay India 28 1.4k 0.8× 352 0.6× 407 0.9× 369 0.8× 265 0.7× 230 2.9k
M. Loredana Marcovecchio Italy 34 1.6k 0.9× 531 0.9× 721 1.6× 438 1.0× 716 1.8× 120 3.7k
Billy S. Collins United States 16 2.7k 1.6× 856 1.5× 682 1.5× 758 1.7× 497 1.3× 35 3.9k
David N. O’Neal Australia 26 1.8k 1.0× 979 1.7× 378 0.8× 275 0.6× 734 1.9× 172 3.1k
Sandra Pinho Silveiro Brazil 24 965 0.6× 515 0.9× 251 0.6× 443 1.0× 242 0.6× 91 3.0k
Peter Winocour United Kingdom 29 1.3k 0.8× 693 1.2× 309 0.7× 509 1.1× 245 0.6× 118 3.2k
Mirela Jobim de Azevedo Brazil 31 1.3k 0.8× 515 0.9× 939 2.1× 539 1.2× 263 0.7× 97 4.2k

Countries citing papers authored by Mary Lou Perry

Since Specialization
Citations

This map shows the geographic impact of Mary Lou Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Lou Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Lou Perry more than expected).

Fields of papers citing papers by Mary Lou Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Lou Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Lou Perry. The network helps show where Mary Lou Perry may publish in the future.

Co-authorship network of co-authors of Mary Lou Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Lou Perry. A scholar is included among the top collaborators of Mary Lou Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Lou Perry. Mary Lou Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guevara‐Cruz, Martha, Adriana Flores‐López, Silvia Carrillo‐Domínguez, et al.. (2023). Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation. Frontiers in Nutrition. 10. 1156995–1156995. 11 indexed citations
2.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S267–S278. 113 indexed citations breakdown →
3.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S128–S139. 145 indexed citations breakdown →
4.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 7. Diabetes Technology: Standards of Care in Diabetes2023. Diabetes Care. 46(Supplement_1). S111–S127. 196 indexed citations breakdown →
5.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S10–S18. 90 indexed citations
6.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 6. Glycemic Targets: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S97–S110. 411 indexed citations breakdown →
7.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 13. Older Adults: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S216–S229. 126 indexed citations breakdown →
8.
ElSayed, Nuha A., Grazia Aleppo, Vanita R. Aroda, et al.. (2022). 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023. Diabetes Care. 46(Supplement_1). S140–S157. 559 indexed citations breakdown →
9.
Sears, B., Mary Lou Perry, & Asish K. Saha. (2020). Dietary Technologies to Optimize Healing from Injury-Induced Inflammation. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 20(2). 123–131. 3 indexed citations
10.
Perry, Mary Lou, et al.. (2019). Approaches to Reducing Chronic Absenteeism.. 1 indexed citations
11.
Kanim, Linda E.A., B. Sears, Mary Lou Perry, et al.. (2019). Omega-3 Fatty Acid Supplementation Reduces Intervertebral Disc Degeneration. Medical Science Monitor. 25. 9531–9537. 19 indexed citations
13.
Sears, B. & Mary Lou Perry. (2015). The role of fatty acids in insulin resistance. Lipids in Health and Disease. 14(1). 121–121. 408 indexed citations breakdown →
16.
Perry, Mary Lou, et al.. (2010). Course-Taking Patterns, Policies, and Practices in Developmental Education in the California Community Colleges. A Report to the California Community Colleges Chancellor's Office.. 4 indexed citations
17.
Taylor, Angela M., et al.. (2005). Outcomes of a multidisciplinary team approach to cardiovascular risk reduction in patients with diabetes mellitus. Therapy. 2(4). 587–595. 6 indexed citations
18.
Perry, Mary Lou. (1996). Treating obesity in people with learning disabilities.. PubMed. 92(35). 36–8. 3 indexed citations
19.
Egan, M. Winston, et al.. (1981). The Training and Evaluation of Preservice Multidisciplinary Teams. Teacher Education and Special Education The Journal of the Teacher Education Division of the Council for Exceptional Children. 4(1). 18–24. 2 indexed citations
20.
Perry, Mary Lou, et al.. (1979). “The Least Restrictive Environment” Social Studies Goals and Practices. The Social Studies. 70(3). 108–111. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026